Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 15, 2009

Premium

The Personalized Medicine Coalition said last week that it has appointed Dietrich Stephan and Clay Marsh to serve on its board of directors.

Stephan is founder and chief science officer of Navigenics. He is also founder and CEO of the recently created Ignite Institute, and he also founded Amnestix and Aeuon. He previously served as a senior investigator in neurogenomics and deputy director of discovery research at the Translational Genomics Research Institute.

Marsh is director of the Center for Critical Care and executive director of the Center for Personalized Medicine at the Ohio State University Medical Center.


Osmetech Molecular Diagnostics has named John Bellano to be senior vice president of commercial operations. Bellano recently was VP of sales at Third Wave Technologies, a position he continued to hold after Third Wave was acquired by Hologic in 2008.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.